Experimental cancer drug trial halted early
NCT ID NCT03522142
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 18 times
Summary
This early-phase study tested a new drug called INCB081776, alone or with another drug, in 83 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Erasmus Medical Center
Rotterdam, 3015 GD, Netherlands
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Haukeland University Hospital
Bergen, 05021, Norway
-
Karolinska University Hospital Solna
Stockholm, 171 76, Sweden
-
Md Anderson Cancer Center
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Netherlands Cancer Institute Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, 1066 CX, Netherlands
-
Odense University Hospital
Odense C, 05000, Denmark
-
Rigshospitalet Uni of Hospital of Copenhagen
Copenhagen, 02100, Denmark
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Skane University Hospital Lund
Lund, 22185, Sweden
-
University Medical Center Groningen
Groningen, 9713GZ, Netherlands
-
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15232, United States
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
-
Utprøvingsenheten, Oslo University Hospital Radiumhospitalet
Oslo, 00379, Norway
-
Yale Cancer Center
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.